Back to top
more

SPDR S&P Pharmaceuticals ETF: (XPH)

(Delayed Data from NYSE) As of Oct 30, 2025 04:00 PM ET

$49.28 USD

49.28
36,293

+0.73 (1.50%)

Volume: 36,293

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

After-Market: $49.25 -0.03 (-0.06 %) 7:58 PM ET

ETF Quote Details

Previous Close 48.55
Open 48.55
Bid 48.87
Ask 49.64
Day Low-High 48.55-49.62
52wk Low-High 35.22-49.62
Volume 36,293
NAV (month end) 47.99
Premium (+)/Discount (-) (month end)+0.56

Zacks Premium Research for XPH

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

 Hold 3
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

High
ETF Research Report

ETF Expense Ratio

Expense Ratio 0.35%
Dividend (Yield) $0.51 (1.04%)
Issuer STATE STREET INVESTMENT MANAGEMENT

Benchmark for XPH

SP PHARMACEUTICALS SELECT INDUSTRY INDEX

The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the US common stocks listed on the NYSE, AMEX, NASDAQ National Market and NASDAQ Small Cap exchanges. The Pharmaceuticals Index is a modified equal weight index.

Fund Summary for XPH

SPDR S&P PHARMACEUTICALS ETF

The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible, before expenses, the total return performance of the S&P Pharmaceuticals Select Industry Index.